Collins Helen Louise

CIK 00017012474 companiesBURLINGAME, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001701247

Recent Transactions

50 trades

Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-06-17−5,000→ 121,268 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-06-17$44.74/sh−1,133→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-06-17$2.48/sh+5,000→ 30,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-06-17$42.83/sh−1,268→ 28,732 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-06-17$43.87/sh−2,599→ 26,133 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2026-06-04+35,000→ 35,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-05-18$40.25/sh−1,302→ 25,223 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-05-18$2.48/sh+5,000→ 30,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-05-18−5,000→ 126,268 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-05-18$41.21/sh−223→ 25,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-05-18$39.53/sh−3,475→ 26,525 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-04-17$48.06/sh−2,441→ 25,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-04-17$47.39/sh−2,419→ 27,441 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-04-17−5,000→ 131,268 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-04-17$2.48/sh+5,000→ 30,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-04-17$45.81/sh−140→ 29,860 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-03-25−40,000→ 136,268 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-25$2.48/sh+40,000→ 65,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-25$35.10/sh−40,000→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-17$2.48/sh+5,000→ 30,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-17$27.76/sh−5,000→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-03-17−5,000→ 176,268 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-10$30.19/sh−10,129→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-03-10−10,129→ 181,268 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-10$2.48/sh+10,129→ 35,129 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-09$30.02/sh−29,871→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-03-09$2.48/sh+29,871→ 54,871 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-03-09−29,871→ 191,397 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-17$26.17/sh−45,000→ 25,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-17$2.48/sh+45,000→ 70,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-17−45,000→ 221,268 total
Award
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-12+25,000→ 25,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-12+150,000→ 150,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2025-06-05+28,500→ 28,500 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2025-06-05+35,144→ 35,144 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$2.48/sh+816→ 816 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−816→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-10-18−816→ 266,268 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2024-06-06+45,642→ 45,642 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2024-06-05+26,000→ 26,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$2.48/sh+20,000→ 20,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−20,000→ 267,084 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.07/sh−20,000→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+185,000→ 185,000 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2023-11-15+64,238→ 64,238 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2023-05-31+26,000→ 26,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2023-04-04+206,000→ 206,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2023-02-23+287,084→ 287,084 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2022-06-21+23,000→ 23,000 total

Companies

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 205 PARK ROAD

BURLINGAME, CA, 94010

View on SEC.gov